SCM
VYGR icon

Sterling Capital Management’s Voyager Therapeutics VYGR Stock Holding History

Sterling Capital Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.71K Sell
1,060
-482
-31% -$1.83K ﹤0.01% 2772
2026
Q1 		$5.95K Sell
1,542
-1,143
-43% -$4.5K ﹤0.01% 2654
2025
Q4 		$10.6K Sell
2,685
-529
-16% -$2.34K ﹤0.01% 2578
2025
Q3 		$15K Buy
3,214
+1,915
+147% +$6.93K ﹤0.01% 2278
2025
Q2 		$4.04K Buy
1,299
+505
+64% +$1.63K ﹤0.01% 2627
2025
Q1 		$2.68K Sell
794
-680
-46% -$3.18K ﹤0.01% 2471
2024
Q4 		$8.36K Buy
1,474
+1,328
+910% +$8.56K ﹤0.01% 2243
2024
Q3 		$854 Buy
+146
New +$1.06K ﹤0.01% 2620

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sterling Capital Management's VYGR Position: Q2 2026 in Review

Sterling Capital Management reduced its Voyager Therapeutics (VYGR) stake by 31% in Q2 2026, selling an estimated $1.83K and leaving 1,060 shares worth $3.71K. The position accounts for ﹤0.01% of the portfolio, ranked #2772.

Sterling Capital Management first reported a position in VYGR in Q3 2024 and has held it in 8 quarters since. The position peaked at $15K in Q3 2025. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Sterling Capital Management held 1,060 shares of Voyager Therapeutics worth $3.71K as of Q2 2026.
  • Sterling Capital Management sold 482 Voyager Therapeutics shares in Q2 2026, an estimated $1.83K.
  • Voyager Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2772 holding.
  • Sterling Capital Management first reported a position in Voyager Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Voyager Therapeutics position peaked at $15K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.